Gynecologic Symptoms among Hormone Receptor-Positive Breast Cancer Patients on Oral Endocrine Therapy: A Cross-Sectional Study

Endocrine therapy (ET) for hormone receptor-positive (HR+) breast cancer can contribute to gynecologic symptoms (GS) that impact vaginal health, sexual function, and quality of life (QoL). A cross-sectional study was conducted at St. Michael’s Hospital in Toronto, Canada between July 2017 and June 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Moskalewicz, Alexandra, Di Tomaso, Amy, Kachura, Jacob J., Scime, Samantha, Nisenbaum, Rosane, Lee, Ronita, Haq, Rashida, Derzko, Christine, Brezden-Masley, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947613/
https://www.ncbi.nlm.nih.gov/pubmed/35323349
http://dx.doi.org/10.3390/curroncol29030149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947613/
https://www.ncbi.nlm.nih.gov/pubmed/35323349
http://dx.doi.org/10.3390/curroncol29030149

Ejemplares similares